Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Astria Therapeutics, Inc. (ATXS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Fairmount Funds Management LLC reports a 6.9% stake in Astria Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Cormorant Asset Management, LP reports a 6.3% stake in Astria Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/24/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 9.7% stake in Astria Therapeutics Inc. |
| 02/08/2022 |
SC 13G/A
| Fairmount Funds Management LLC reports a 7% stake in Astria Therapeutics, Inc. |
| 09/22/2021 |
SC 13G/A
| Fairmount Funds Management LLC reports a 7.6% stake in Astria Therapeutics, Inc. |
| 07/09/2021 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 2% stake in CATABASIS PHARMACEUTICALS, INC. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/10/2020 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 7.6% stake in CATABASIS PHARMACEUTICALS, INC. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 3.3% stake in Catabasis Pharmaceuticals, Inc. |
| 02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 6.6% stake in Catabasis Pharmaceuticals, Inc. |
| 02/13/2019 |
SC 13G/A
| FEDERATED INVESTORS INC reports a 14.7% stake in CATABASIS PHARMACEUTICALS, INC. |
| 01/17/2019 |
SC 13G/A
| Empery Asset Management, LP reports a 0.7% stake in Catabasis Pharmaceuticals, Inc. |
| 02/14/2018 |
SC 13G/A
| Advanced Technology Ventures VIII LP reports a 4.9% stake in Catabasis Pharmaceuticals, Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
|
|